Neurosense Therapeutics Eulerpool News

Neurosense Therapeutics Eulerpool News

Neurosense Therapeutics Stock News

Neurosense Therapeutics is being monitored by journalists and investors worldwide. We gather the latest Neurosense Therapeutics news here.

• August 16 ·

  TipRanks
  NeuroSense Therapeutics Announces Share Issuance
• August 7 ·

  Yahoo
  NeuroSense Therapeutics Announces Private Placement with Senior Management Participation at Premium to Market Price
• August 7 ·

  TipRanks
  NeuroSense Therapeutics Announces Strategic Securities Sale
• August 1 ·

  Yahoo
  NeuroSense Therapeutics Announces Positive Biomarker Data from ALS Phase 2b Clinical Trial
• August 1 ·

  TipRanks
  NeuroSense’s ALS Drug Shows Promise in Trial
• August 1 ·

  Thefly.com
  NeuroSense's PrimeC shows positive biomarker data from ALS Phase 2b trial
• July 9 ·

  Yahoo
  NeuroSense's PARADIGM ALS Clinical Trial Demonstrates Up to 73% Improved Complication-Free Survival Following Statistically Significant Slowing of Disease Progression
• July 1 ·

  Yahoo
  NeuroSense Demonstrates Statistically Significant Efficacy and Survival Benefits in People Living with ALS: The Promising Results from the 12-Month PARADIGM Study Highlight PrimeC's Potential as a Disease Modifying Drug
• June 27 ·

  TipRanks
  NeuroSense Extends Warrant Termination, Revises Terms
• June 24 ·

  Yahoo
  NeuroSense Management Provides Corporate Update and First Quarter 2024 Financial Results